We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page
| Stock ticker: | BMY |
| Name: | BRISTOL-MYERS SQUIBB COMPANY |
| Sector: | Healthcare |
| Investing Risk: | LOW |
| Forecast length: | 1 months, 18 days |
| Accuracy: | 45.57 % |
| Average profit per target: | 6.53 % |
| Signal Date | Signal Price | Date Reached | Price Reached | Profit | Direction |
|---|---|---|---|---|---|
| 2024-04-16 | 45.4 $ | 2024-05-28 | 38.09 $ | 16.1% | |
| 2024-04-23 | 46.09 $ | 2024-05-21 | 39.77 $ | 13.72% | |
| 2024-10-08 | 50.68 $ | 2024-11-11 | 57.77 $ | 13.99% | |
| 2024-10-15 | 50.95 $ | 2024-11-11 | 57.77 $ | 13.38% | |
| 2024-10-22 | 50.95 $ | 2024-11-11 | 57.77 $ | 13.38% | |
| 2024-10-29 | 50.7 $ | 2024-11-11 | 57.77 $ | 13.94% | |
| 2024-11-12 | 57 $ | 2025-03-10 | 61.62 $ | 8.11% | |
| 2024-11-19 | 56.24 $ | 2025-03-10 | 61.62 $ | 9.58% | |
| 2024-11-26 | 56.73 $ | 2025-03-10 | 61.62 $ | 8.63% | |
| 2024-12-10 | 56.13 $ | 2025-03-10 | 61.62 $ | 9.78% | |
| 2025-01-23 | 57.74 $ | 2025-02-14 | 52.63 $ | 8.86% | |
| 2025-02-18 | 53.15 $ | 2025-03-07 | 59.65 $ | 12.24% | |
| 2025-02-20 | 54.47 $ | 2025-04-10 | 49.8 $ | 8.57% | |
| 2025-02-21 | 54.51 $ | 2025-04-10 | 49.8 $ | 8.64% | |
| 2025-04-11 | 50.05 $ | 2025-05-14 | 43.55 $ | 13% | |
| 2025-04-14 | 50.67 $ | 2025-05-14 | 43.55 $ | 14.06% | |
| 2025-04-15 | 49.35 $ | 2025-05-14 | 43.55 $ | 11.76% | |
| 2025-04-17 | 48.59 $ | 2025-05-14 | 43.55 $ | 10.38% | |
| 2025-04-21 | 48.3 $ | 2025-05-14 | 43.55 $ | 9.85% | |
| 2025-04-23 | 47.9 $ | 2025-05-14 | 43.55 $ | 9.09% | |
| 2025-05-02 | 49.91 $ | 2025-05-14 | 43.55 $ | 12.75% | |
| 2025-05-02 | 49.91 $ | 2025-05-14 | 43.55 $ | 12.75% | |
| 2025-05-05 | 49.41 $ | 2025-05-14 | 43.55 $ | 11.87% |
June 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug ~1 min.Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....
June 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu ~1 min.Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....
May 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit ~2 min.QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin ~2 min.On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success ~2 min.On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis ~1 min.BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit ~1 min.On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit ~1 min.On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis ~1 min.On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis ~1 min.BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform....
